In vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation

Journal of Virology

Volumn 82, Issue 20, 2008, Pages 10302-10307

  Gustems, Montse ^a   Busche, Andreas ^b   Messerle, Martin ^b   Ghazal, Peter ^c   Angulo, Ana ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CHIMERA; COMPETENCE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENHANCER REGION; EXPERIMENTAL MODEL; GENE CONTROL; HUMAN CYTOMEGALOVIRUS; IN VIVO STUDY; MAJOR IMMEDIATE EARLY ENHANCER; MOUSE; MURINE CYTOMEGALOVIRUS; NEWBORN; NONHUMAN; ORGAN; PHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERTANT; STRAIN DIFFERENCE; VIRUS GENE; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; BETAHERPESVIRINAE; CELL LINE; DISEASE MODEL; FEMALE; GENETICS; HUMAN; METABOLISM; PATHOGENICITY; PATHOLOGY; VIRUS ACTIVATION;

ANIMALIA; HUMAN HERPESVIRUS 5; MURID HERPESVIRUS 1; MURINAE; MUS;

HYBRID PROTEIN; IMMEDIATE EARLY PROTEIN;

ANIMALS; ANIMALS, NEWBORN; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENHANCER ELEMENTS (GENETICS); FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; RECOMBINANT FUSION PROTEINS; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 53749099521     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01255-08     Document Type: Article

References (37)

1. Amicone, L., F. M. Spagnoli, G. Späth, S. Giordano, C. Tommasini, S. Bernardini, V. De Luca, C. Della Rocca, M. C. Weiss, P. M. Comoglio, and M. Trípoli. 1997. Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes. EMBO J. 16:495-503.
2. Angulo, A., M. Messerle, U. H. Koszinowski, and P. Ghazal. 1998. Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer. J. Virol. 72:8502-8509.
3. Baskar, J. F., P. P. Smith, G. S. Climent, S. Hoffman, C. Tucker, D. J. Tenney, A. M. Colberg-Poley, J. A. Nelson, and P. Ghazal. 1996. Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J. Virol. 70:3215-3226.
4. Baskar, J. F., P. P. Smith, G. Nilaver, R. A. Jupp, S. Hoffmann, N. J. Peffer, D. J. Tenney, A. M. Colberg-Poley, P. Ghazal, and J. A. Nelson. 1996. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J. Virol. 70:3207-3214.
5. Benedict, C. A., A. Angulo, G. Patterson, S. Ha, H. Huang, M. Messerle, C. F. Ware, and P. Ghazal. 2004. Neutrality of the NF-κB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro. J. Virol. 78:741-750.
6. Borst, E. M., C. Benkartek, and M. Messerle. 2007. Use of bacterial artificial chromosomes in generating targeted mutations in human and mouse cytomegaloviruses, p. 10.32.1-10.32.20. In J. E. Coligan, B. Bierer, D. H. Marguiles, E. M. Sherach, W. Strober, and R. Coico (ed.), Current protocols in immunology. John Wiley & Sons, New York, NY.
7. Boshart, M., F. Weber, G. Jahn, K. Dorsch-Hasler, B. Fleckenstein, and W. Schaffner. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521-530.
8. Busche, A., A. Angulo, P. Kay-Jackson, P. Ghazal, and M. Messerle. 2008. Phenotypes of major immediate-early gene mutants of mouse cytomegalovirus. Med. Microbiol. Immunol. 197:233-240.
9. Caposio, P., A. Luganini, G. Hahn, S. Landolfo, and G. Gribaudo. 2007. Activation of the virus-induced IKK/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells. Cell. Microbiol. 9:2040-2054.
10. Dorsch-Hasler, K., G. M. Keil, F. Weber, M. Jasin, W. Schaffner, and U. H. Koszinowski. 1985. A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc. Natl. Acad. Sci. USA 82:8325-8329.
11. Ebeling, A., G. M. Keil, E. Knust, and U. H. Koszinowski. 1983. Molecular cloning and physical mapping of murine cytomegalovirus DNA. J. Virol. 47:421-433.
12. Ghazal, P., and J. A. Nelson. 1993. Transcription factors and viral regulatory proteins as potential mediators of human cytomegalovirus pathogenesis, p. 360-383. In Y. Becker, G. Darai, and E.-S. Huang (ed.), Molecular aspects of human cytomegalovirus diseases. Springer-Verlag Publishers, Heidelberg, Germany.
13. Ghazal, P., M. Messerle, K. Osborn, and A. Angulo. 2003. An essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis. J. Virol. 77:3217-3228.
14. Grzimek, N. K. A., J. Podlech, H.-P. Steffens, R. Holtappels, S. Schmalz, and M. J. Reddehase. 1999. In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus. J. Virol. 73:5043-5055.
15. Gustems, M., E. Borst, C. A. Benedict, C. Pérez, M. Messerle, P. Ghazal, and A. Angulo. 2006. Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-κB binding sites in the enhancer. J. Virol. 80:9899-9904.
16. Hudson, J. B., V. Misra, and T. R. Mosmann. 1976. Cytomegalovirus infectivity: analysis of the phenomenon of centrifugal enhancement of infectivity. Virology 72:235-243.
17. Hummel, M., and M. M. Abecassis. 2002. A model for reactivation of CMV from latency. J. Clin. Virol. 25:S123-S136.
18. Isomura, H., and M. F. Stinski. 2003. The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection. J. Virol. 77:3602-3614.
19. Isomura, H., M. F. Stinski, A. Kudoh, T. Daikoku, N. Shirata, and T. Tsurumi. 2005. Two SP1/Sp3 binding sites in the major immediate-early proximal enhancer of human cytomegalovirus have a significant role in viral replication. J. Virol. 79:9597-9607.
20. Isomura, H., T. Tsurumi, and M. F. Stinski. 2004. Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication. J. Virol. 78:12788-12799.
21. Jordan, M. C., and V. L. Mar. 1982. Spontaneous activation of latent cytomegalovirus from murine spleen explants. J. Clin. Investig. 70:762-768.
22. Keller, M. J., D. G. Wheeler, E. Cooper, and J. L. Meier. 2003. Role of the human cytomegalovirus major immediate-early promoter's 19-base-pair-repeat cyclic AMP-response element in acutely infected cells. J. Virol. 77:6666-6675.
23. Koedood, M., A. Fichtel, P. Meier, and P. J. Mitchell. 1995. Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J. Virol. 69:2194-2207.
24. Krmpotic, A., M. Messerle, I. Crnkovic-Mertens, B. Polic, S. Jonjic, and U. H. Koszinowski. 1999. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J. Exp. Med. 190:1285-1296.
25. Meier, J. L., and M. F. Stinski. 2006. Major immediate-early enhancer and its gene products, p. 151-166. In M. J. Reddehase (ed.) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Wymondham, United Kingdom.
26. Meier, J. L., and J. A. Pruessner. 2000. The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate early gene expression. J. Virol. 74:1602-1613.
27. Meier, J. L., M. J. Keller, and J. J. McCoy. 2002. Requirement of multiple cis-acting elements in the human cytomegalovirus major immediate-early distal enhancer for viral gene expression and replication. J. Virol. 76:313-326.
28. Mocarski, E. S., and C. T. Courcelle. 2001. Cytomegaloviruses and their replication, p. 2629-2673. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
29. Netterwald, J., S. Yang, W. Wang, S. Ghanny, M. Cody, P. Soteropoulus, B. Tian, W. Dunn, F. Liu, and H. Zhu. 2005. Two gamma interferon-activated site-like elements in the human cytomegalovirus major immediate-early promoter/enhancer are important for viral replication. J. Virol. 79:5035-5046.
30. Pass, R. F. 2001. Cytomegalovirus, p. 2675-2705. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
31. Presti, R. M., J. L. Pollock, A. J. Dal Canto, A. K. O'Guin, and H. W. Virgin IV. 1998. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J. Exp. Med. 188:577-588.
32. Reddehase, M. J., M. Balthesen, M. Rapp, S. Jonjic, I. Pavic, and U. H. Koszinowski. 1994. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179:185-193.
33. Reddehase, M. J., J. Podlech, and N. K. A. Grzimek. 2002. Mouse models of cytomegalovirus latency: overview. J. Clin. Virol. 25:S23-S36.
34. Sandford, G. R., L. E. Brock, S. Voigt, C. M. Forester, and W. H. Burns. 2001. Rat cytomegalovirus major immediate-early enhancer switching results in altered growth characteristics. J. Virol. 75:5076-5083.
35. Sinclair, J., and P. Sissons. 2006. Latency and reactivation of HCMV. J. Gen. Virol. 87:1763-1779.
36. Stinski, M. F., and H. Isomura. 2008. Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency. Med. Microbiol. Immunol. 197:223-231.
37. Wagner, M., S. Jonjic, U. H. Koszinowski, and M. Messerle. 1999. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73:7056-7060.